A blockbuster breast cancer niche has Roche and Sanofi in the lead

A blockbuster breast cancer niche has Roche and Sanofi in the lead

From Novartis, Bristol MS meds to new ADCs, here are 2020’s blockbuster drug launches

From Novartis, Bristol MS meds to new ADCs, here are 2020's blockbuster drug launches

Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook

Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook

10 Takeover Targets to Watch This Fall

10 Takeover Targets to Watch This Fall

5 questions ESMO cancer drug data might answer

5 questions ESMO cancer drug data might answer

The top 10 drug launches of 2019

The top 10 drug launches of 2019